D-Tartaric acid → (R)-3-(2-ethoxyphenoxy)piperidine D-tartrate

HRID 59890

Reaktionsgleichung

Cl.[CH2:2]([O:4][C:5]1[CH:17]=[CH:16][CH:15]=[CH:14][C:6]=1[O:7][CH:8]1[CH2:13][CH2:12][CH2:11][NH:10][CH2:9]1)[CH3:3].[C:18]([OH:27])(=[O:26])[C@H:19]([C@@H:21]([C:23]([OH:25])=[O:24])[OH:22])[OH:20]>CC(C)=O>[C:23]([C@H:21]([C@@H:19]([C:18]([OH:27])=[O:26])[OH:20])[OH:22])([OH:25])=[O:24].[CH2:2]([O:4][C:5]1[CH:17]=[CH:16][CH:15]=[CH:14][C:6]=1[O:7][C@@H:8]1[CH2:13][CH2:12][CH2:11][NH:10][CH2:9]1)[CH3:3]

Komponenten

Reaktionsbedingungen

Temperatur: 20 °C

Versuchsvorschrift

A slurry of 3-(2-ethoxyphenoxy)piperidine hydrochloride (200 g, 0.776 mol) and D-tartaric acid (118 g, 776 mol) in acetone (3.0 L) was warmed to 56° C. and was held at that temperature for 2 hours. The mixture was cooled to 20° C. and was held at that temperature overnight. The crystals were collected by filtration, rinsing with acetone (1 L), and then were dried to afford (R)-3-(2-ethoxyphenoxy)piperidine D-tartrate (145 g). Chiral HPLC analysis indicated an enantiomeric ratio of 99.5:0.5 (Chiralpak AD-H, 4.6×250 mm, 5 μm, 210 nM, 0.2% isopropylamine-isopropanol, 0.7 mL/min; retention times 5.76 min (major enantiomer), 6.20 min (minor enantiomer). 1H NMR (400 MHz, DMSO-d6) δ 12.69 (br s, 1.5H), 9.34 (br s, 1H), 8.79 (br s, 1H), 7.12 (d, 1H), 7.03 (m, 2H), 6.89 (m, 1H), 5.09 (br s, 1.5H), 4.44 (m, 1H), 4.32 (s, 2H), 4.05 (q, 2H), 3.28 (m, 1H), 3.11 (m, 1H), 3.04 (m, 2H), 1.97 (m, 1H), 1.92 (m, 1H), 1.72 (m, 2H), 1.35 (s, 3H).

Aufarbeitung

customwas held at that temperature overnight
filtrationThe crystals were collected by filtration
washrinsing with acetone (1 L)
customwere dried

Quellen und Nachweise

ORD-Eintrag: ord-2dea284770954f6aa09f05d071ff4d54
Quelldatensatz: uspto-grants-2016_09
DOI: 10.6084/m9.figshare.5104873.v1
Patentnummer: US09440949B2

Verknüpfte Notizen

Wird geladen…